GNH USA

Europe — EMA

Menopur (Menotrophin)

GNH USA supplies Menopur (Menotropin), a gonadotropin for infertility due to anovulation and ovarian stimulation in reproduction. Request a quote for supply.

Menotrophin

Request sourcing

1
Pack/s

What is Menotrophin?

Menotropin, the active ingredient in Menopur, is a gonadotropin presented as a powder for solution for injection for intramuscular and subcutaneous use. It treats infertility due to anovulation, supports controlled ovarian stimulation for assisted reproductive technologies, and addresses hypogonadotropic hypogonadism. It is derived from purified urinary extracts of postmenopausal women and is used under specialist supervision.

GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides reliable cold‑chain logistics for injectable biologics.

What is Menotrophin used for?

Menopur, a gonadotropin used in reproductive hormone therapy, is indicated for: - Infertility due to anovulation: stimulates follicular development to enable ovulation. - Controlled ovarian stimulation for assisted reproductive technologies (e.g., IVF): promotes multiple follicle growth for egg retrieval. - Hypogonadotropic hypogonadism: provides FSH and LH activity to restore endogenous hormone production.

What are the side effects of Menotrophin?

Menopur may cause a range of adverse reactions, which are generally related to its hormonal activity and injection site.

Common Side Effects: - Abdominal discomfort or bloating - Injection site pain or erythema - Mild headache - Nausea - Mild ovarian hyperstimulation (e.g., mild ovarian enlargement) - Fatigue

Serious or Rare Side Effects: - Severe ovarian hyperstimulation syndrome (OHSS) - Multiple pregnancy - Ovarian torsion - Allergic reaction or anaphylaxis - Thromboembolic events - Ectopic pregnancy

What precautions apply to Menotrophin?

When using Menopur, several precautions should be observed to minimize risks and ensure optimal outcomes. - Dose individualization: dosing should be individualized by the prescriber based on ovarian response. - Monitoring: regular ultrasound and estradiol monitoring is required during treatment. - Risk of OHSS: patients at risk should be identified and closely observed for signs of ovarian hyperstimulation. - Pregnancy considerations: use only under specialist supervision and discontinue if contraindicated. - Contraindications: avoid in active ovarian cysts, uncontrolled thyroid disease, estrogen‑dependent tumors or severe ovarian failure. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Menotrophin interact with?

Menopur can interact with other medicines, affecting its efficacy or safety profile.

Major Interactions (Avoid): - GnRH agonists: concurrent use may exacerbate ovarian hyperstimulation. - Estrogen‑containing oral contraceptives: may blunt ovarian response. - Other gonadotropins: additive effect can increase risk of OHSS. - Anticoagulants: heightened risk of thromboembolic events when OHSS occurs.

Moderate Interactions (Monitor Closely): - Thyroid hormone therapy: hormonal changes may require dose adjustment. - Corticosteroids: may influence hormone metabolism and response. - Insulin or oral hypoglycemics: monitor glucose levels due to hormonal effects.

Frequently asked questions

What is Menopur used for?+
Menopur is a gonadotropin preparation indicated for the treatment of infertility caused by anovulation, for controlled ovarian stimulation in assisted reproductive technologies such as in vitro fertilisation, and for managing hypogonadotropic hypogonadism by providing both FSH and LH activity to support normal ovarian function.
How does menotropin work?+
Menotropin contains purified follicle‑stimulating hormone (FSH) and luteinizing hormone (LH). These hormones bind to specific receptors on ovarian granulosa and theca cells, activating intracellular signalling pathways that promote follicular growth, estrogen production, and ovulation, while LH supports luteinisation and progesterone synthesis.
What determines the dose of Menopur?+
The dose of Menopur is individualized by the treating physician based on the patient’s age, ovarian reserve, response to prior stimulation cycles, and the specific goals of the assisted reproduction protocol. The prescriber adjusts the amount and timing according to ultrasound and hormonal monitoring.
Is Menopur safe during pregnancy or breastfeeding?+
Menopur is not intended for use during an established pregnancy, and its safety in pregnancy has not been established. Women who become pregnant while on treatment should be managed by a specialist. Limited data are available for breastfeeding, so use is generally avoided unless the benefit outweighs potential risk.
How do I order Menopur from GNH USA?+
To order Menopur, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and the necessary import documentation.
How does Menopur compare with other gonadotropin products?+
Menopur provides a fixed combination of FSH and LH activity, whereas some alternatives such as recombinant FSH contain only FSH. The presence of LH in Menopur can be advantageous for patients with a documented LH deficiency, but the choice depends on individual response, protocol design and physician preference.
What are the storage and handling requirements for Menopur?+
Menopur should be stored at 2‑8 °C (refrigerated) in its original packaging, protected from light. Do not freeze or shake the vial. Once reconstituted, the solution should be used within the time frame specified in the product label and kept refrigerated until administration.
How is Menopur administered?+
Menopur is supplied as a powder for solution for injection. After reconstitution with the appropriate diluent, it is administered by a subcutaneous or intramuscular injection according to the dosing schedule prescribed by the fertility specialist, typically once daily during the stimulation phase.
What are the most serious risks associated with Menopur?+
The most serious risks include severe ovarian hyperstimulation syndrome (OHSS), which can cause abdominal pain, fluid accumulation, and thromboembolic complications, as well as multiple pregnancy, ovarian torsion, and rare allergic reactions such as anaphylaxis. Prompt medical attention is required if any of these occur.
Who should not use Menopur?+
Menopur should not be used in women with active ovarian cysts, uncontrolled thyroid disease, estrogen‑dependent tumours, severe ovarian failure, or known hypersensitivity to menotropin or any excipients. It is also contraindicated in patients who are pregnant, breastfeeding, or for whom assisted reproductive techniques are not indicated.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Menotrophin
Route
Intramuscular Use , Subcutaneous Use
Manufacturer
Ferring Léciva A.S.
Origin
EU

Related products

Menogon Hp

Menogon Hp

Menotrophin

Ferring Gmbh
EU
Menopur

Menopur

Menotrophin

Ferring Arzneimittel Ges.M.B.H.
EU
Menopur

Menopur

Menotrophin

Ferring N.V.
EU
Menopur

Menopur

Menotrophin

Ferring Gmbh
EU